591
Dietary soy-phytoestrogens decrease testosterone levels and
prostate weight without altering LH, prostate 5-reductase or
testicular steroidogenic acute regulatory peptide levels in adult
male Sprague–Dawley rats
K S Weber, K D R Setchell1, D M Stocco2 and E D Lephart
Neuroscience Center, Brigham Young University, Provo, Utah 86402, USA
1
Clinical Mass Spectrometry Center, Children’s Hospital Medical Center, Cincinnati, Ohio 45229, USA
2
Department of Cell Biology and Biochemistry, Texas Tech University Health Sciences Center, Lubbock, Texas 79430, USA
(Requests for offprints should be addressed to E D Lephart, Neuroscience Center, 633 WIDB, Brigham Young University, Provo, Utah 84602, USA;
Email: Edwin_Lephart@byu.edu)
Abstract
Nutritional factors, especially phytoestrogens, have been
extensively studied for their potential beneficial effects
against hormone-dependent and age-related diseases. The
present study describes the short-term effects of dietary
phytoestrogens on regulatory behaviors (food/water
intake, locomotor activity and body weight), prostate
weight, prostate 5-reductase enzyme activity, reproductive hormone levels, and testicular steroidogenic acute
regulatory peptide (StAR) levels in adult Sprague–Dawley
rats.
Animals were fed either a phytoestrogen-rich diet
containing ]600 µg/g isoflavones (as determined by
HPLC) or a phytoestrogen-free diet. After 5 weeks of
consuming these diets, plasma phytoestrogen levels were
35 times higher in animals fed the phytoestrogen-rich vs
phytoestrogen-free diets. Body and prostate weights were
significantly decreased in animals fed the phytoestrogenrich diet vs the phytoestrogen-free fed animals; however,
no significant change in prostate 5-reductase enzyme
activity was observed between the treatment groups.
Locomotor activity levels were higher in the
Introduction
Phytoestrogens (a group of natural selective estrogen
receptor modulators) are non-steroidal, diphenolic
structures found in many plants (e.g. fruits, vegetables,
legumes, whole grain and especially soy products) that
have the capacity to bind estrogen receptors ( and )
(Bradbury & White 1954, Price & Fenwick 1985, Setchell
& Adlercreutz 1988, Knight & Eden 1996, Adlercreutz
1997, Kuiper et al. 1997, Setchell & Cassidy 1999). These
estrogen mimics have been shown in animal models and
in limited clinical investigations to be protective in the
prevention of: (1) hormone-dependent cancers (e.g. breast
phytoestrogen-rich vs the phytoestrogen-free animals
during the course of the treatment interval. Plasma testosterone and androstenedione levels were significantly lower
in the animals fed the phytoestrogen-rich diet compared
with animals fed the phytoestrogen-free diet. However,
there were no significant differences in plasma LH or
estradiol levels between the diet groups. Testicular StAR
levels were not significantly different between the
phytoestrogen-rich vs the phytoestrogen-free fed animals.
These results indicated that consumption of dietary
phytoestrogens resulting in very high plasma isoflavone
levels over a relatively short period can significantly alter
body and prostate weight and plasma androgen hormone levels without affecting gonadotropin or testicular
StAR levels.
The findings of this study identify the biological actions
of phytoestrogens on male reproductive endocrinology and
provide insights into the protective effects these estrogen
mimics exert in male reproductive disorders such as
benign prostatic hyperplasia and prostate cancer.
Journal of Endocrinology (2001) 170, 591–599
and prostate), (2) cardiovascular disease and (3) osteoporosis (Price & Fenwick 1985, Setchell & Adlercreutz 1988,
Knight & Eden 1996, Adlercreutz 1997, Adlercreutz &
Mazur 1997, Setchell 1998, Kumar & Besterman-Dahan
1999, Setchell & Cassidy 1999, Adlercreutz et al. 2000).
The anti-cancer effects of phytoestrogens appear to be
associated with several possible mechanisms, including
their ability to inhibit tyrosine kinase(s), growth factors,
DNA isotopoisomerase, steroidogenic enzymes and act as
anti-oxidant and anti-angiogenic agents (Price & Fenwick
1985, Setchell & Adlercreutz 1988, Knight & Eden 1996,
Adlercreutz 1997, Adlercreutz & Mazur 1997, Griffiths
et al. 1998, Setchell 1998, Setchell & Cassidy 1999).
Journal of Endocrinology (2001) 170, 591–599
0022–0795/01/0170–591 2001 Society for Endocrinology Printed in Great Britain
Online version via http://www.endocrinology.org
592
K S WEBER
and others ·
Dietary phytoestrogens in adult rats
Epidemiological data have shown clear relationships
between the incidence rates of prostate cancer (PCa) and
soy food consumption. In Japan, the incidence of PCa is
relatively low compared with that in the USA. Yet,
despite the Japanese developing benign prostatic hyperplasia (BPH), rarely does it progress to a malignant cancer
condition. This observation has led to the belief that
phytoestrogen-rich diets may explain these observations
(Adlercreutz 1997, Adlercreutz & Mazur 1997, Griffiths
et al. 1998, Kumar & Besterman-Dahan 1999, Setchell &
Cassidy 1999, Adlercreutz et al. 2000). Support for this
hypothesis comes from rodent studies where soy diets have
been found to be protective against PCa cell growth
(Makela et al. 1995a, Zhang et al. 1997, Dalu et al. 1998,
Landstrom et al. 1998, Bylund et al. 2000, Choi et al.
2000). Several human studies suggest that phytoestrogens
inhibit BPH and PCa growth in vitro and in vivo (Stephens
1997, Griffiths et al. 1998, Stephens 1999, Choi et al.
2000). In the USA (and in other developed countries),
PCa is the second most common cause of cancer death and
BPH is a pre-malignant condition representing a major
health concern in men. If a dietary approach to preventing
either condition proves successful, this will have global
implications. For this reason, we have attempted to
determine whether high dietary phytoestrogen intake
influences reproductive endocrine physiology in adult
male rats in a manner that may be beneficial with regard
to prevention of these diseases.
In this study, adult male Sprague–Dawley rats were fed
either a high phytoestrogen diet or a phytoestrogen-free
diet for approximately 5 weeks. Regulatory behaviors
(food and water intake) and locomotor (open field) activity
were measured along with recording body and prostate
weight, prostate 5-reductase enzyme activity, plasma
testosterone, androstenedione, estradiol, luteinizing hormone (LH) and testicular steroidogenic acute regulatory
protein (StAR) levels at the end of the study.
after as the Phyto-free diet) or (2) the phytoestrogen-rich
containing diet (referred to hereafter as the Phyto-600
diet). There were no significant differences in body
weight before the animals were assigned to the treatment
groups and the animals continued to have free access to
water and the diets. The Phyto-free rat diet was obtained
from Zeigler Brothers (Gardner, PA, USA), balanced and
matched for equivalent percentage content of protein,
carbohydrate and fat to that of the commercially available
Phyto-600 diet (Harlan-Teklad, Madison, WI, USA). The
ingredients for each diet are compared in Table 1. The
concentration and type(s) of phytoestrogens in the two
diets were analyzed in duplicate by reverse-phase high
pressure liquid chromatography (HPLC) using a
250·46 cm Aquapore (C8; particle size 7 µm) column
(Perkin Elmer, Bodman Industries, Aston, PA, USA)
under gradient elution conditions, with internal controls,
as described elsewhere (Coward et al. 1993, Setchell et al.
1997). The Phyto-600 diet contained approximately
600 µg/g phytoestrogens while the phytoestrogen content
in the Phyto-free diet was below the limits of HPLC
detection (see Table 2).
Food (g0·1 g), water (m0·5 ml) and body weight
(g0·1 g) measurements were recorded periodically
throughout the study. Food intake was recorded by
weighing each animal’s food tray every 24 h during the
treatment interval. Water intake was measured in ml from
calibrated water bottles. After 35 days on the treatment
diets (starting at 70 days of age), the male rats were killed
at 105 days of age. At the time of death, trunk blood
was collected, body weight was measured and ventral
prostate weight determined (mg0·5 mg). Plasma was
prepared from the trunk blood and stored at −20 C
until assayed. The animals and methods used in this study
were approved by the Institutional Animal Care and Use
Committee at Brigham Young University.
Plasma phytoestrogen levels
Materials and Methods
Animals
Adult male Sprague–Dawley (50-day-old) rats were
obtained from Simonsen Laboratories (Gilroy, CA, USA)
and were housed in a controlled environment on a reverse
light–dark cycle (lights on 1600 to 0600 h; red light
illumination during the dark cycle from 0600 to 1600 h).
The animals were given free access to water and standard
rat chow for approximately 20 days (days 50–70). The
standard rat chow diet contains approximately 300 µg/g
phytoestrogens.
Phytoestrogen diets
At 70 days of age, 114 rats were randomly assigned to two
treatment groups: (1) a sterol-free diet (referred to hereJournal of Endocrinology (2001) 170, 591–599
The concentration and type(s) of phytoestrogens were
analyzed from two pooled (by treatment) plasma (in a
subset of animals, total n=31 per treatment) samples by
gas-chromatography/mass spectrometry. This was preformed by liquid–solid extraction and liquid–gel chromatographic techniques to isolate the phytoestrogen fractions
using standard methods with stable isotopic labeled internal standards and control samples to validate the assay
(Setchell et al. 1997). Concentrations are expressed in
ng/ml.
Locomotor activity
In a subset of animals (n=18 per group), before the diets
were initiated, at 70 days of age and after the diets were
administered, at 82 days of age (or 12 days on the diets) and
at 99 days of age (or 29 days on the diets) the locomotor
www.endocrinology.org
Dietary phytoestrogens in adult rats ·
Table 1 Treatment diets
Unit
Harlan-Teklad
8604
Zeigler Bros,
sterol free
Nutrient composition
Protein
Fat
Fiber
Ash
Linoleic acid
%
%
%
%
%
24·48
4·40
3·69
7·84
1·87
23·14
5·69
2·30
6·46
2·19
Amino acids
Arginine
Methionine
Cystine
Histidine
Isoleucine
Leucine
Lysine
Phenylalanine+tyrosine
Threonine
Tryptophan
Valine
%
%
%
%
%
%
%
%
%
%
%
1·53
0·42
0·37
0·58
1·24
2·04
1·46
1·84
0·94
0·29
1·26
1·13
0·59
0·27
0·59
1·19
2·17
1·42
2·08
0·95
0·26
1·36
Minerals
Calcium
Phosphorus
Sodium
Chlorine
Potassium
Magnesium
Sulfur
Iron
Manganese
Zinc
Copper
Iodine
Cobalt
Selenium
%
%
%
%
%
%
%
mg/kg
mg/kg
mg/kg
mg/kg
mg/kg
mg/kg
mg/kg
1·36
1·01
0·29
0·49
1·04
0·28
NA
352·14
105·39
82·87
24·42
2·46
0·71
0·33
1·20
0·96
0·30
0·43
0·55
0·16
0·20
245·49
96·21
59·81
13·06
1·84
0·52
0·37
Vitamins
Vitamin A
Vitamin D3
Vitamin E
Choline
Niacin
Pantothenic acid
Pyridoxine (vitamin B6)
Riboflavin (vitamin B2)
Thiamine (vitamin B1)
Menadione (vitamin K3)
Folic acid
Biotin
Vitamin B12
Vitamin C
IU/g
IU/g
IU/kg
mg/g
mg/kg
mg/kg
mg/kg
mg/kg
mg/kg
mg/kg
mg/kg
mg/kg
mg/kg
mg/kg
12·90
2·40
90·18
2·53
63·42
21·03
12·95
7·85
27·95
4·11
2·72
0·39
51·20
0·00
6·59
5·08
48·84
1·65
76·56
31·74
9·89
6·92
17·35
3·14
3·01
0·37
47·88
0·00
The ingredients list (first four) for the Harlan-Teklad 8604 diet=soybean
meal, corn and wheat flakes, ground corn and wheat middlings; for the
Zeigler Brothers, sterol-free diet=corn, wheat, fish meal and wheat
middlings (reproduced by permission of the suppliers).
NA, not assayed.
activity of the rats from each diet group was measured by
open field tests (conducted at 1000–1200 h (during the
dark cycle when rats are most active) under red light
conditions, as previously described; Lephart et al. 1996,
www.endocrinology.org
K S WEBER
and others
Table 2 HPLC analysis of phytoestrogen content (g/g) of the
Phyto-600 and Phyto-free diets. Duplicate samples of each diet
(Harlan-Teklad 8604 (Phyto-600) and Zeigler Brothers, sterol-free
(Phyto-free)) were analyzed by reverse phase HPLC (Coward et al.
1993, Setchell et al. 1997)
Phyto-600
Phyto-free
Daidzin
Glycitin
Genistin
Acetylglucoside daidzein
Acetylglucoside glycitin
Daidzein
Glycitein
Genistein
198·2
47·8
286·1
32·4
18·6
10·3
3·3
9·5
199·0
45·8
276·9
35·6
23·4
9·6
4·7
8·6
ND
ND
ND
NA
NA
ND
NA
ND
ND
ND
ND
NA
NA
ND
NA
ND
Total (µg/g)
606·6
603·6
ND
ND
ND=none detected (below the limits of HPLC detection, less than
0·5 g/g); NA=not assayed.
Weber et al. 1999). One rat (per open field test by
treatment) was placed on a round table (1·22 m in diameter, 0·91 m off of the ground with 1010 cm boxed
grids), and the ambulatory activity was videotaped. Later,
three different observers counted the number of squares
that each rat entered in three minutes. The locomotor
activity levels were averaged (for each animal by treatment
per open field test), and the correspondence (analyzed
by correlational analysis; Pearson Product Moment
Correlation) among the three observers in recording open
field behavior was r=0·98 for the entire testing interval.
Radioimmunoassay – determination of plasma testosterone,
androstenedione, estradiol and LH levels
In a subset of the treated animals (n=18 per group), plasma
testosterone, androstenedione and estradiol levels were
determined by radioimmunoassay (RIA) using kits from
Diagnostic Systems Laboratories (Webster, TX, USA).
The estradiol values were obtained using an ultra-sensitive
kit (RIA). All samples were run in a single assay (in
duplicate by hormone tested) and the intra-assay coefficients of variation were 3% for testosterone, 4% for
androstenedione and 7% for estradiol. LH levels were
measured using reagents obtained from the National
Hormone and Pituitary Program. The results obtained are
expressed in terms of the LH-RP3 reference standards and
the sensitivity of this assay was 0·07 ng/ml (Niswender
et al. 1968). The samples were run in a single assay in
duplicate with an intra-assay coefficient of variation <7%.
Prostate 5-reductase activity
To determine 5-reductase activity in ventral prostate
tissue (in a subset of animals, n=13 per group), the isolated
tissue samples were incubated in 200 µl Dulbecco’s
Journal of Endocrinology (2001) 170, 591–599
593
594
K S WEBER
and others ·
Dietary phytoestrogens in adult rats
minimum essential medium (DMEM) at pH 7·0 (Sigma
Chemical Co., St Louis, MO, USA) with a saturating
concentration of [1-3H]testosterone as the substrate
(3·0 µM; DuPont/New England Nuclear Corp., Boston,
MA, USA) for 1 h. Using standard assay procedures
(Lephart et al. 1990), the rates of 5-reductase activity in
each tissue sample were determined in the reaction
mixture. In brief, at the end of the incubation period,
the reaction was stopped and steroids in the reaction
mixture were extracted with 5 vol. chloroform with
subsequent vortexing. An aliquot of the chloroform phase
(100 µl) was evaporated to dryness, re-dissolved in 30 µl
chloroform containing 10 µg each of five non-radioactive
steroids (5-androstane-3,17-dione, androstenedione,
5-dihydrotestosterone, testosterone and 5-androstane3,17-diol). Each prepared sample was applied to precoated silica gel plastic thin layer chromatography (TLC)
plates (2020 cm). The TLC plates were developed with
one ascent of the solvent system (dichloromethane, ethyl
acetate, methanol; 85:15:3, by vol.), which resolves the
major 5-reduced metabolites from 5-androgen metabolites, estradiol and estrone. The tritium corresponding to
the cold 5-reduced steroids was quantified by scintillation
counting to calculate the 5-reductase activities as corrected by blanks (reaction tubes containing no tissue) as
standards (Lephart et al. 1990). Using these conditions, the
predominant enzyme activity measured was 5-reductase
type 1 (Normington & Russell 1992) which apparently is
the major 5-reductase type expressed in adult rat prostate
tissue (Normington & Russell 1992). The protein content
of each tissue fragment assayed was determined by the
method of Lowry et al. (1951). The 5-reductase activities
were expressed as specific activity rate(s) in pmol/h (of
incubation)/mg protein.
Testicular StAR protein Western analysis
The right testis of each Phyto-600 or Phyto-free animal
(n=13 per diet group) was dissected and then stored at
–85 C until assayed. The following procedure was performed in a cold room (4 C). The testicular tissues (by
treatments) were thawed, cut into small sections and
placed into 30 ml ice-cold TBS buffer, pH 7·0. The
testicular tissues were dispersed by passing the tissue/
buffer mixture through an 18 gauge needle, then a 20
gauge needle five times each. The dispersed testicular
tissue was then placed into a 50 ml conical tube for 5 min
to allow the larger cell particles consisting of pieces of
seminiferous tubules to settle to the bottom of the tube.
Subsequently, 1 ml aliquots of the dispersed testicular
tissue were collected for the upper portion of the conical
tube, the protein content of each aliquot was determined
by a Lowry protein assay (Lowry et al. 1951) and finally the
samples were lyophilized. Lyophilized Leydig cell samples
were analysed for expression of StAR by Western analysis
as described previously (Clark et al. 1994). The samples
Journal of Endocrinology (2001) 170, 591–599
were solubilized in sample buffer (25 mM Tris/HCl,
pH 6·8, 1% SDS, 5% -mercaptoethanol, 1 mM EDTA,
4% glycerol and 0·01% bromophenol blue), boiled for
5 min and loaded onto a 12% SDS-PAGE mini-gel
(Mini-Protean II System; Bio-Rad, Richmond, CA,
USA). Electrophoresis was performed at 200 V for 45 min
using a standard SDS-PAGE running buffer (25 mM Tris,
192 mM glycine, 0·1% SDS, pH 8·3). The proteins
were electrophoretically transferred to a polyvinylidene
difluoride membrane (Bio-Rad, Hercules, CA, USA) at
100 V for 2 h at 4 C using a transfer buffer containing
20 mM Tris, 150 mM glycine, 20% methanol, pH 8·3.
The membrane was incubated in blocking buffer (PBS
buffer containing 4% Carnation non-fat dry milk and 0·2%
Tween 20), at room temperature for 1 h followed by
incubation with a primary antibody against StAR for
30 min. Anti-StAR antisera against amino acids 88–98
of mouse StAR protein were produced in rabbits by
Research Genetics (Huntsville, AL, USA). The membrane was washed with PBS containing 0·2% Tween 20
three times for 10 min each time. After incubation with
the second antibody, donkey anti-rabbit IgG conjugated
with horseradish peroxidase (Amersham, Arlington
Heights, IL, USA), the membrane was washed five times
for 10 min each time. Specific protein bands were
detected by chemiluminescence using the Renaissance
Kit (Dupont New England Nuclear, Wilmington, DE,
USA), and quantitated using the BioImage Visage 2000
(Townson et al. 1996).
Statistical analysis
The data derived from the adult male rats were tested by
ANOVA, followed by pairwise comparisons (via Tukey’s
analysis) to detect significant differences between the
treatment groups (=P<0·05). For the open field data,
repeated measures were used to detect significant
differences between the treatment groups, followed by a
post-hoc pairwise comparison via a Neuman–Kuels test
(=P<0·05).
Results
The total and individual isoflavones were determined in
pooled plasma samples from animals in each diet group.
The animals in the Phyto-600 group had significantly
higher levels of phytoestrogens in their plasma compared with the Phyto-free treatment group (Fig. 1). The
total circulating concentration of plasma isoflavones was
approximately 35 times higher in the Phyto-600
(2224 ng/ml) vs the Phyto-free (63 ng/ml) animals. Major
components of the plasma phytoestrogen levels in the
Phyto-600 animals were equol (]1000 ng/ml) and
daidzein (]800 ng/ml) while genistein (]400 ng/ml)
made up the remaining fraction of the circulating
www.endocrinology.org
Dietary phytoestrogens in adult rats ·
K S WEBER
and others
Figure 1 Plasma phytoestrogen concentrations from adult male rats fed the Phyto-600 or the Phyto-free
diets for 5 weeks, expressed in ng/ml (means S.E.M.). Phytoestrogen concentrations were measured by gas
chromatography/mass spectrometry (Setchell et al. 1997). n=31, this represents the total of two
independently pooled plasma samples assayed for each treatment. Total=sum of the three main
phytoestrogen metabolites (equol, daidzein and genistein). Significantly higher plasma phytoestrogen levels
in the Phyto-600 vs the Phyto-free animals is represented by the solid star.
isoflavones. In the Phyto-free group, the phytoestrogens
(equol, daidzein and genistein) were present in plasma but
at very low concentrations compared with the Phyto-600
values (Fig. 1).
For food intake, there were no significant differences
between the Phyto-600 vs the Phyto-free fed animals near
the end of the treatment interval (see Table 3). However,
when water intake was examined, Phyto-600 fed animals
Table 3 Food and water intake and body and prostate weights of
male rats fed the Phyto-600 vs the Phyto-free diets. Values are
means S.E.M. (n=57)
Food intake (g)
Water intake (ml)
Body weight (g)
Prostate weight (mg)
Prostate weight/body weight (ratio)
Phyto-600
Phyto-free
22·50·4
28·00·5#
372·84·0
561·513·0
145·64·2
21·70·4
26·00·5
391·63·4*
605·814·1*
157·63·7*
Food and water intake represent the last 3 days of the diet treatment
interval (averaged before the animals were killed at 120 days of age). Body
and prostate weights were determined at the time of death.
There were no significant differences in body weight by diet treatment
group (at 70 days of age) before the treatment diets were administered (i.e.
Phyto-600 group=304·32·7 g vs Phyto-free group=304·72·9 g).
#Significantly greater water intake compared with Phyto-free values;
*significantly greater values compared with Phyto-600 values.
www.endocrinology.org
displayed slight but significantly higher levels than Phytofree fed animals (Table 3). Also, when body weight was
measured at the end of the treatment period (compared to
pre-treatment values), we observed a slight but significant
decrease in body weight in the Phyto-600 (372·8 + 4·0 g)
compared with the Phyto-free fed (391·6 + 3·4 g) animals
(Table 3).
Since there were no significant differences in food
intake between the Phyto-600 vs the Phyto-free animals,
open field tests were conducted to determine whether
locomotor activity levels were altered by the diets (Fig. 2).
There were no significant differences in open field activity
before the animals were fed the Phyto-600 vs the Phytofree diets. However, after 12 days and at 29 days of feeding
on the diets, the Phyto-600 group displayed higher open
field locomotor levels compared with the Phyto-free
group although the difference did not quite approach
statistical significance (P<0·06) (Fig. 2), suggesting a
potential influence of dietary phytoestrogens on locomotor
activity.
For animals fed the Phyto-600 diet, the prostate weight
(alone or standardized by body weight) was significantly
lower compared with the Phyto-free group (see Table 3).
In order to gain an understanding of this result, prostate
5-reductase activity was measured, since androgen hormonal action (via 5-dihydrotestosterone) is known to act
Journal of Endocrinology (2001) 170, 591–599
595
596
K S WEBER
and others ·
Dietary phytoestrogens in adult rats
18
18
Phyto
Phyto
600
free
Pre-treatment
18
18
Phyto
600
Phyto
free
12 days treatment
18
18
Phyto
Phyto
600
free
29 days treatment
Figure 2 Open field activity of Phyto-600 vs Phyto-free fed male rats. The columns indicate
the mean number of squares the rats, by treatment group, entered in a 3-min time-period
(Lephart et al. 1996, Weber et al. 1999). Each bar represents the mean S.E.M. for open
field activity and the number at the base of each bar indicates the total animals tested per
treatment group. The open field activity levels for the Phyto-600 group at 12 and
29 days of treatment approached significance where the Phyto-600 group displayed higher
locomotor activity levels than the Phyto-free group values (P<0·060, 12 days treatment;
and P<0·065, 29 days treatment).
as a trophic signal in this organ. There were no significant differences between the diet groups for prostate
5-reductase activity (Phyto-600=113·03·0 pmol/h
of incubation/mg protein vs Phyto-free=117·5
4·5 pmol/h of incubation/mg protein, n=13 per treatment group; data not shown graphically). Therefore, other
hormonal signals were analyzed to potentially identify how
a significant decrease in ventral prostate weight in the
Phyto-600 group occurred.
There was no significant difference in plasma LH values
between the animals fed the two phytoestrogen diets
(Table 4); however, a significant decrease in plasma
testosterone concentrations was observed for animals fed
Table 4 Testosterone, LH, androstenedione and estradiol levels in
male rats fed the Phyto-600 vs the Phyto-free diets. Values are
means S.E.M. (n=18)
Testosterone (ng/ml)
LH (ng/ml)
Androstenedione (ng/ml)
Estradiol (pg/ml)
Phyto-600
Phyto-free
1·30·2
0·400·05
0·0150·001
4·20·42
2·60·3*
0·370·08
0·0970·014*
4·50·80
*Significantly greater values compared with Phyto-600 values.
Journal of Endocrinology (2001) 170, 591–599
the Phyto-600 vs the Phyto-free diets (Table 4). In fact,
plasma testosterone levels were approximately 50% lower
in animals fed the Phyto-600 compared with animals fed
the Phyto-free diet.
To further determine the pattern of steroidogenesis in
the Phyto-600 and Phyto-free animals, plasma androstenedione and estradiol levels were also measured by
RIA (Table 4). A significant decrease in plasma androstenedione levels was observed in the animals fed the
Phyto-600 diet compared with the Phyto-free fed animals
(Table 4). The plasma androstenedione concentrations
showed the same pattern as that of the plasma testosterone
levels, being significantly lower in animals fed the
Phyto-600 diet (Table 4). However, in the case of
androstenedione, there was a much greater reduction in
the Phyto-600 animals vs the Phyto-free fed animals when
compared with the testosterone results. Conversely, when
plasma estradiol levels were determined, no significant
differences were observed between the two groups of
animals (Table 4).
To examine whether the significant decrease in plasma
testosterone observed in the Phyto-600 diet fed animals
was related to changes in testicular StAR protein, levels of
this protein were measured by Western analysis. There
were no significant differences in testicular StAR protein
levels between the two groups (data not shown).
www.endocrinology.org
Dietary phytoestrogens in adult rats ·
Finally, when testicular characteristics were examined,
there were no significant differences in testes weight,
Sertoli or Leydig cell number or morphology between
the Phyto-600 vs the Phyto-free fed animals (data not
shown).
Discussion
Interest in the health effects of phytoestrogens has
increased dramatically during the past years where agerelated and hormone-dependent diseases appear to be
influenced by the consumption of these plant estrogen-like
molecules (Setchell & Adlercreutz 1988, Knight & Eden
1996, Adlercreutz 1997, Adlercreutz & Mazur 1997,
Murkies et al. 1998, Setchell 1998, Kumar & BestermanDahan 1999, Setchell & Cassidy 1999, Adlercreutz et al.
2000). The present study attempts to understand the
possible mechanisms of action of phytoestrogens as they
relate to PCa prevention by examining hormonal, reproductive and behavioral responses in an animal model fed a
phytoestrogen-rich diet.
The content of the phytoestrogen diet utilized in this
study was similar to that previously used. The total
isoflavone concentration was approximately 600 µg/g
phytoestrogens (designated as the Phyto-600 diet), while
the Phyto-free diet had no detectable isoflavones by
HPLC with UV detection (Lephart et al. 2000). The
circulating plasma phytoestrogen concentration of animals
fed the Phyto-600 diet (]2200 ng/ml) is similar to that in
people eating a typical Asian diet (of approximately 1 µM).
Animals fed the Phyto-free diet had very low plasma
phyotestrogens levels (]70 ng/ml) reflecting what is
observed in humans consuming a typical Western diet. By
this approach, we are effectively establishing a dietary
model for comparing Asian with Western diets for the
consumption of phytoestrogens.
Estrogens are known to alter feeding behavior, bodyweight composition and significantly increase locomotor
behavior in rats (Gray et al. 1979, Mooradian et al. 1987).
In this study, animals fed the Phyto-600 diet displayed a
slight but significant decrease in body weight after 5 weeks
on this diet compared with animals fed the Phyto-free diet
and this is consistent with the estrogenic hormonal action
of these molecules (Mooradian et al. 1987, Anderson et al.
1988). Furthermore, since phytoestrogens have been
shown to transfer into brain tissue (Lephart et al. 2000) and
have similar physiochemical and physiological characteristics to endogenous estrogens (Setchell & Adlercreutz
1988, Knight & Eden 1996, Adlercreutz 1997, Murkies
et al. 1998, Setchell 1998, Setchell & Cassidy 1999,
Adlercreutz et al. 2000), locomotor behavior tests revealed
that Phyto-600 fed animals showed slight (but nonsignificant; P<0·06) increases in open field behavior
compared with the animals fed a Phyto-free diet.
This significant decrease in body weight observed in
www.endocrinology.org
K S WEBER
and others
these animals fed the Phyto-600 diet suggests that the
Phyto-600 diet may increase locomotor activity. (In
another study, we have data to support the notion that
Phyto-600 fed animals display significantly increased
locomotor activity; however, we have also obtained preliminary data where significant differences in absorption/
metabolism may account for the differences in body
weight where alterations in leptin and adipose tissue
deposition are seen between Phyto-600 and Phyto-free
fed animals.)
Long-term dietary studies where animals have been
exposed to phytoestrogens show influences on prostate and
other markers of reproductive development (Sharma et al.
1992, Makela et al. 1995a, Zhang et al. 1997). When
reproductive organs were examined, Phyto-600 fed
animals displayed a significant reduction in ventral prostate
weight compared with Phyto-free fed animals. The mechanism for this change is unknown but may relate to
changes in steroid hormone status within the prostate itself
by effects on the levels of enzymes regulating steroid
hormone production. It is known that phytoestrogens can
inhibit prostate 5-reductase enzyme activity in vitro
(Evans et al. 1995), but our studies did not find significant
alterations in prostate 5-reductase enzyme activity after
feeding the Phyto-600 diet that could account for the
changes in prostate weight.
However, the Phyto-600 fed animals had significantly
lower plasma androgen levels when compared with the
Phyto-free fed animals. This reduction in testosterone
could account for the reduced prostate weight in these
animals, because the ventral prostate is androgen sensitive.
In previous (longer term) studies, changes in androgen
levels were not noted (Sharma et al. 1992, Makela et al.
1995a, Zhang et al. 1997); however, circulating phytoestrogen levels were not measured in these studies and,
therefore, such differences are difficult to reconcile.
Additionally, we have previously observed a similar
pattern of circulating testosterone reduction in animals on
the Phyto-600 diet (at approximately 40–50% of Phytofree values) in three independent studies under the same
experimental conditions, representing an n of 39 rats per
treatment group. Another possible explanation for this
finding is that phytoestrogens have the ability to inhibit
the aromatase enzyme in peripheral tissues (Kellis &
Vickery 1984, Ibrahim & Abul-Hajj 1990, Adlercreutz
et al. 1994, Wang et al. 1994) and the apparent protection
phytoestrogens have against BPH and PCa may be via the
reduction in local estrogen formation since estrogenic
agents are known to be mitogenic (vom Saal et al. 1997,
Griffiths et al. 1998, Farnsworth 1999, Shibata et al. 2000,
Yaono et al. 2000).
On the other hand, the inter-conversion of testosterone
to androstenedione is regulated by the activity of 17hydroxysteroid dehydrogenase, an enzyme that has been
shown to be influenced by phytoestrogens (Makela et al.
1995b). Changes in plasma androstenedione levels with
Journal of Endocrinology (2001) 170, 591–599
597
598
K S WEBER
and others ·
Dietary phytoestrogens in adult rats
the Phyto-600 diet were much lower compared with
those observed for testosterone by dietary treatments,
suggesting that the substrate supply or enzyme regulation
for testosterone synthesis may be affected by the
phytoestrogen-rich diet. No changes in plasma LH or
estradiol levels were observed between the Phyto-600
animals and the Phyto-free fed animals that could account
for the changes in the observed testosterone levels. Finally,
in an attempt to determine whether phytoestrogens may
alter cholesterol delivery into the steroidogenic pathway,
we measured StAR activity but found no significant differences in testicular StAR levels between the
Phyto-600 and the Phyto-free groups. However, it is
possible that the 30 kDa StAR protein analyzed in these
experiments may not represent newly synthesized StAR
and thus the protein measured would not be active in
cholesterol transfer (Townson et al. 1996). It is also possible
that the effects of phytoestrogens may be manifested at the
level of protein kinase activity in the prostate. It is known
that genistein decreases tyrosine phosphorylation in
endocrine tissue (Fioravanti et al. 1998). Finally, the
decrease in testosterone levels in the Phyto-600 animals
remains to be explained but represents a consistent
observation (Sharma et al. 1992, Landstrom et al. 1998). It
is possible that phytoestrogens affect the biosynthetic
pathways for androgen production by an unknown
mechanism.
The reduction in prostate weight in the Phyto-600 fed
animals is in agreement with findings by other investigators. Soy-containing diets were shown to inhibit prostatitis and prostate adenocarcinoma in rodents and to
reduce prostate size in humans with BPH (Sharma et al.
1992, Stephens 1997, 1999, Griffiths et al. 1998, Landstrom et al. 1998, Adlercreutz et al. 2000, Bylund et al.
2000). However, in the above rodent studies, prostatic
parameters were reduced without changes in testosterone
levels among the treatment groups (Sharma et al. 1992,
Landstrom et al. 1998). Thus, the mechanisms across
species and presumably among rat strains may represent
diverse and complex processes by which phytoestrogens
protect against certain types of hormone-dependent
cancers and BPH (vom Saal et al. 1997, Griffiths et al.
1998, Farnsworth 1999, Negri-Cesi et al. 1999, Shibata
et al. 2000, Yaono et al. 2000).
In summary, the findings of this study highlight the
biological actions of phytoestrogens on male reproductive endocrinology and may explain, in part, the protective effect of these estrogen mimics in male
reproductive disorders such as BPH and PCa.
Acknowledgements
This work was supported, in part, by grants from the
National Science Foundation, IBN-9507972 (to E D L),
and the National Institutes of Health, HD 17481 (to
Journal of Endocrinology (2001) 170, 591–599
D M S). The authors thank Dr Les Dees at Texas A&M
for performing the LH assays.
References
Adlercreutz H 1997 Evolution, nutrition, intestinal microflora, and
prevention of cancer: a hypothesis. Proceedings of the Society for
Experimental Biology and Medicine 217 241–246.
Adlercreutz H & Mazur W 1997 Phyto-estrogens and Western diets.
Annals of Medicine 29 95–120.
Adlercreutz H, Bannwart C, Wahala K, Makela T, Brunow G, Hase
T, Arosemena PJ, Kellis JT Jr & Vickery LE 1994 Inhibition of
human aromatase by mammalian lignans and sioflavonoid
phytoestrogens. Journal of Steroid Biochemistry and Molecular Biology 44
147–153.
Adlercreutz H, Mazur W, Bartels P, Elomaa V, Watanabe S, Wahala
K, Landstrom M, Lundin E, Bergh A, Damber JE, Aman P,
Widmark A, Johansson A, Zhang JX & Hallmans G 2000
Phytoestrogens and prostate disease. Journal of Nutrition 130
658S–659S.
Anderson WR, Simpkins JW, Brewster ME & Bodor N 1988 Effects
of a brain-enhanced chemical delivery system for estradiol on body
weight and serum hormones in middle-aged male rats. Endocrine
Research 14 131–148.
Bradbury RB & White DE 1954 Estrogens and related substances in
plants. Vitamins and Hormones 12 207–233.
Bylund A, Zhang JX, Bergh A, Damber JE, Widmark A, Johansson
A, Adlercreutz H, Aman P, Shepherd MJ & Hallmans G 2000 Rye
bran and soy protein delay growth and increase apoptosis of human
LNCap prostate adenocarcinoma in nude mice. Prostate 42
304–314.
Choi YH, Lee WH, Park KY & Zhang I 2000 p53-Independent
induction of p21 (WAF1/CIPI), reduction of cyclin B1 and G2/M
arrest by the isoflavone genistein in human prostate carcinoma cells.
Japanese Journal of Cancer Research 91 164–173.
Clark BJ, Wells J, King SR & Stocco DM 1994 The purification,
cloning and expression of a novel LH-induced mitochondrial
protein in MA-10 mouse Leydig tumor cells: characterization of the
steroidogenic acute regulatory protein (StAR). Journal of Biological
Chemistry 269 28314–28322.
Coward L, Barnes NC, Setchell KDR & Barnes S 1993 Genistein,
daidzein, and their -glycoside conjugates: antitumor isoflavones in
soybean foods from American and Asian diets. Journal of Agriculture
and Food Chemistry 41 1961–1967.
Dalu A, Haskel JF, Coward L & Lamartiniere CA 1998 Genistein, a
component of soy, inhibits the expression of the EGF and
ErbB2/Neu receptors in the rat dorsolateral prostate. Prostate 37
36–43.
Evans BA, Griffiths K & Morton MS 1995 Inhibition of 5-reductase
in genital skin fibroblasts and prostate tissue by dietary lignans and
isoflavonoids. Journal of Endocrinology 147 295–302.
Farnsworth WE 1999 Estrogen in the etiopathogenesis of BPH.
Prostate 41 263–274.
Fioravanti L, Cappelletti V, Miodini P, Ronchi E, Brivio M &
DiFronzo G 1998 Genistein in the control of breast cancer cell
growth: insights into the mechanism of action in vitro. Cancer Letters
30 143–152.
Gray JM, Nunez AA, Siegel LI & Wade GN 1979 Effects of
testosterone on body weight and adipose tissue: role of
aromatization. Physiology and Behavior 23 465–469.
Griffiths K, Denis L, Turkes A & Morton MS 1998 Phytoestrogens
and diseases of the prostate gland. Baillieres Clinical Endocrinology and
Metabolism 12 625–647.
Ibrahim AR & Abul-Hajj YJ 1990 Aromatase inhibition by flavonoids.
Journal of Steroid Biochemistry and Molecular Biology 37 257–260.
Kellis JT Jr & Vickery LE 1984 Inhibition of human estrogen
synthetase (aromatase) by flavones. Science 225 1032–1034.
www.endocrinology.org
Dietary phytoestrogens in adult rats ·
Knight DC & Eden JA 1996 A review of the clinical effects of
phytoestrogens. Obstetrics and Gynecology 87 897–904.
Kuiper GGJM, Carlsson B, Grandien K, Enmark E, Haggbald J,
Nilsson S & Gustafsson J 1997 Comparison of the ligand binding
specificity and transcript tissue distribution of estrogen receptors
and . Endocrinology 138 863–870.
Kumar NB & Besterman-Dahan K 1999 Nutrients in the chemoprevention of prostate cancer: current and future prospects. Cancer
Control 6 580–586.
Landstrom M, Zhang JX, Hallmans G, Aman P, Bergh A, Damber JE,
Mazur W, Wahala K & Adlercreutz H 1998 Inhibitory effects of
soy and rye diets on the development of Dunning R3327 prostate
adenocarcinoma in rats. Prostate 36 151–61.
Lephart ED, Andersson S & Simpson ER 1990 Expression of neural
5-reductase messenger ribonucleic acid: comparison to
5-reductase activity during prenatal development in the rat.
Endocrinology 127 1121–1128.
Lephart ED, Ladle DR, Jacobson NA & Rhees RW 1996 Inhibition
of brain 5-reductase in pregnant rats: effects on enzymatic and
behavioral activity. Brain Research 739 356–360.
Lephart ED, Thompson JM, Setchell KDR, Adlercreutz H & Weber
KS 2000 Phytoestrogens decrease brain calcium-binding proteins
but do not alter hypothalamic androgen metabolizing enzymes in
adult male rats. Brain Research 859 123–131.
Lowry OH, Rosebrough NJ, Farr AL & Randall RJ 1951 Protein
determination with the Folin phenol reagent. Journal of Biological
Chemistry 193 265–275.
Makela SI, Pylkkanen LH, Santti RS & Adlercreutz H 1995a Dietary
soybean may be antiestrogenic in male mice. Journal of Nutrition 125
437–445.
Makela S, Poutanen M, Lehtimaki J, Kostian M-L, Santti R & Vihko
R 1995b Estrogen-specific 17-hydroxysteroid oxidoreductase
type 1 (E.C.1·1·1·62) as a possible target for the action of
phytoestrogens. Proceedings of the Society for Experimental Biology and
Medicine 208 51–59.
Mooradian AD, Morley JE & Korenman SG 1987 Biological actions of
androgens. Endocrine Reviews 8 1–28.
Murkies AL, Wilcox G & Davis SR 1998 Phytoestrogens – review.
Journal of Clinical Endocrinology and Metabolism 83 297–303.
Negri-Cesi P, Colciago A, Poletti A & Motta M 1999 5 alphareductase isozymes and aromatase are differentially expressed and
active in the androgen-independent human prostate cancer cell
lines DU145 and PC3. Prostate 41 224–232.
Niswender GD, Midgley AR Jr, Monroe SE & Reichert LE Jr 1968
Radioimmunoassay for rat luteinizing hormone and antiovine LH
serum and ovine LH-131-I. Proceedings of the Society for Experimental
Biology and Medicine 128 807–811.
Normington K & Russell DW 1992 Tissue distribution and kinetic
characteristics of rat 5-reductase isozymes. Journal of Biological
Chemistry 27 19548–19554.
Price KR & Fenwick GR 1985 Naturally occurring oestrogens in
foods – a review. Food Additives and Contaminants 2 73–106.
vom Saal FS, Timms BG, Montano MM, Palanza P, Thayer KA,
Nagel SC, Dhar MD, Ganjam VK, Parmigiani S & Welshons WV
1997 Prostate enlargement in mice due to fetal exposure to low
doses of estradiol or diethylstilbestrol and opposite effects at high
doses. PNAS 94 2056–2061.
www.endocrinology.org
K S WEBER
and others
Setchell KDR 1998 Phytoestrogens: the biochemistry, physiology and
implications for human health of soy isoflavones. American Journal of
Clinical Nutrition 68 1333S–1346S.
Setchell KDR & Adlercreutz H 1988 Mammalian lignans and
phtyo-oestrogens – recent studies on their formation, metabolism
and biological role in health and disease. In Role of the Gut Flora in
Toxicity and Cancer, pp 315–345. Ed. IR Rowland. New York:
Academic Press.
Setchell KDR & Cassidy A 1999 Dietary isoflavones – biological
effects and relevance to human health. Journal of Nutrition 129
758S–767S.
Setchell KD, Zimmer-Nechemias L, Cai J & Heubi JE 1997 Exposure
of infants to phyto-oestrogens from soy-based infant formula. Lancet
350 23–27.
Sharma OP, Adlercreutz H, Strandberg JD, Zirkin BR, Coffey DS &
Ewing LL 1992 Soy of dietary source plays a preventing role against
the pathogenesis of prostatitis in rats. Journal of Steroid Biochemistry
and Molecular Biology 43 4557–4564.
Shibata Y, Ito K, Suzuki K, Nakano K, Fukabori Y, Suzuki R,
Kawabe Y, Honoma S & Yamanaka H 2000 Changes in the
endocrine environment of the human prostate transition zone with
aging: simultaneous quantitative analysis of prostatic sex steroids and
comparison with human prostatic histological composition. Prostate
42 45–55.
Stephens FO 1997 Phytoestrogens and prostate cancer: possible
preventive role. Medical Journal of Australia 167 138–140.
Stephens FO 1999 The rising incidence of breast cancer in women
and prostate cancer in men. Dietary influences: a possible
preventative role for nature’s sex hormone modifiers: the
phytoestrogens. Oncology Reports 6 865–870.
Townson DH, Wang XJ, Keyes PL, Kostyo JL & Stocco DM 1996
Expression of the steroidogenic acute regulatory protein (StAR)
in the corpus luteum of the rabbit: dependence upon the
luteotrophic hormone, 17-estradiol. Biology of Reproduction 55
868–874.
Wang C, Makela T, Hase T, Adlercreutz H & Kurzer MS 1994
Lignans and flavonoids inhibit aromatase enzyme in human
preadipocytes. Journal of Steroid Biochemistry and Molecular Biology 50
205–212.
Weber KS, Jacobson NA, Setchell KDR & Lephart ED 1999 Brain
aromatase and 5-reductase, regulatory behaviors and testosterone
levels in adult rats on phytoestrogen diets. Proceedings of the Society
for Experimental Biology and Medicine 22 131–135.
Yaono M, Tamano S, Mori T, Kato K, Imaida K, Asamoto M &
Shirai T 2000 Lobe specific effects of testosterone and estrogen on
3,2 -dimethyl-4-aminobiphenyl-induced rat prostate carcinogenesis.
Cancer Letters 150 33–40.
Zhang JX, Hallmans G, Landstrom M, Bergh A, Damber JE,
Aman P & Adlercreutz H 1997 Soy and rye diets inhibit the
development of Dunning R3327 prostatic adenocarcinoma in rats.
Cancer Letters 114 313–314.
Received 19 February 2001
Accepted 14 June 2001
Journal of Endocrinology (2001) 170, 591–599
599